DJIA 18,092.02 54.05 0.30%
NASDAQ 5,069.35 9.11 0.18%
S&P 500 2,112.80 3.88 0.18%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Forget Gilead Sciences: Here Are 3 Better Biotech Stocks

Biogen Idec, Regeneron, and Amgen Inc. may be better bets than Gilead Sciences.

Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analy

Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analyst Blog

Biotech Stocks: What's Hot, What's Not - As Seen By Market-Makers, Their Clients

Regeneron's Expanded Pipeline Not A Concern For Morgan Stanley

Baxter Needs To Split Up - Cramer's Lightning Round (2/10/15)

Stock Market News for February 10, 2015 - Market News

Regeneron: Mixed Earnings, But A Leg Up In The Cholesterol Race

Regeneron Beats on Q4 Earnings Driven by Eylea Sales - Analyst Blog

Regeneron Pharmaceuticals (REGN) Earnings Report: Q4 2014 Conference Call Transcript

Regeneron Pharmaceuticals Inc. Earnings: All Eyes on Eylea

Regeneron reported its fourth-quarter and full-year numbers this morning. Here's what investors need to know.